Home › Colorectal Cancer › Texas › Amarillo
Colorectal Cancer clinical trials in Amarillo, TX
3 studies for Colorectal Cancer are looking for participants at sites in and around Amarillo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- The Don and Sybil Harrington Cancer Center, Amarillo
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RecruitingPhase 1/2
- Texas Oncology - West Texas, Amarillo
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Texas Oncology - West Texas, Amarillo
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX101 studies
- New York City, NY86 studies
- Nashville, TN67 studies
- Boston, MA62 studies
- Los Angeles, CA61 studies
- Arlington, VA54 studies
- St. Louis, MO51 studies
- San Antonio, TX43 studies
- Philadelphia, PA41 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Tampa, FL36 studies
Other studies in Amarillo
- Non-Small Cell Lung Cancer9 studies
- Heart Failure8 studies
- Obesity7 studies
- Lung Cancer5 studies
- Overweight4 studies
- Cardiovascular Disease4 studies
- Blood Clots4 studies
- Breast Cancer4 studies
- Coronary Artery Disease3 studies
- Atrial Fibrillation3 studies
- Digestive Diseases3 studies
- Atherosclerosis3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.